Forskolin-resistant Y1 adrenal cell mutants are deficient in adenylyl cyclase type 4

Area of Science:

• Biochemistry
• Cell Biology
• Molecular Endocrinology

Background:

• Y1 mouse adrenocortical tumor cells are a model for studying cellular responses to hormones.
• Forskolin is a direct activator of adenylyl cyclase (AC), an enzyme critical for cyclic AMP (cAMP) production.
• Mutant cell lines resistant to forskolin present an opportunity to identify key components of the forskolin signaling pathway.

Purpose of the Study:

• To investigate the adenylyl cyclase (AC) isoform composition in forskolin-resistant Y1 cell mutants.
• To determine the role of specific AC isoforms in mediating forskolin's effects on Y1 cells.
• To elucidate the molecular basis for forskolin resistance in these mutant cell lines.

Main Methods:

• Western blot analysis to assess protein levels of AC isoforms.
• Reverse transcription-polymerase chain reaction (RT-PCR) to evaluate AC isoform gene expression.
• Gene transfection to restore AC-4 expression in mutant cells.
• Measurement of cAMP signaling and assessment of cellular morphology and growth.

Main Results:

• Four independently derived forskolin-resistant Y1 cell mutants were identified.
• All four mutants exhibited a deficiency in adenylyl cyclase-4 (AC-4) expression.
• Levels of other AC isoforms (AC-1, AC-3, AC-5/6) remained comparable to parental Y1 cells.
• Restoration of AC-4 expression in a mutant clone re-sensitized the cells to forskolin, increasing cAMP signaling and normalizing cell morphology and growth.

Conclusions:

• Deficiency in AC-4 is the underlying cause of forskolin resistance in these Y1 cell mutants.
• AC-4 plays a crucial role in mediating forskolin's effects in the Y1 mouse adrenocortical cell line.
• AC-4 is an important molecular target for forskolin action in adrenal cells.